Hester E de Melker
Overview
Explore the profile of Hester E de Melker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
200
Citations
2851
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van Werkhoven C, de Gier B, McDonald S, de Melker H, Hahne S, van den Hof S, et al.
J Clin Epidemiol
. 2024 Jul;
174:111471.
PMID: 39032589
Objectives: Registration in the Dutch national COVID-19 vaccination register requires consent from the vaccinee. This causes misclassification of nonconsenting vaccinated persons as being unvaccinated. We quantified and corrected the resulting...
12.
Holwerda M, Hoeve C, Huiberts A, Den Hartog G, de Melker H, van den Hof S, et al.
Euro Surveill
. 2024 Jun;
29(25).
PMID: 38904110
BackgroundNon-severe adverse events (AE) including pain at injection site or fever are common after COVID-19 vaccination.AimTo describe determinants of AE after COVID-19 vaccination and investigate the association between AE and...
13.
Vos E, van Hagen C, Wong D, Smits G, Kuijer M, Wijmenga-Monsuur A, et al.
Influenza Other Respir Viruses
. 2024 Jun;
18(6):e13312.
PMID: 38837866
Background: To inform future response planning we aimed to assess SARS-CoV-2 trends in infection- and/or vaccine-induced immunity, including breakthrough infections, among (sub)groups, professions and regions in the Dutch population during...
14.
Haverkate M, Willemstein I, van Ewijk C, Adam P, Lanooij S, Jonker-Jorna P, et al.
Euro Surveill
. 2024 May;
29(21).
PMID: 38785092
BackgroundIn 2022 and 2023, a global outbreak of mpox affected mostly gay, bisexual and other men having sex with men (GBMSM). Outbreak control in the Netherlands included isolation, quarantine, post-exposure...
15.
Sellies A, Knol M, de Melker H, Bruijning-Verhagen P, de Boer A
Vaccine
. 2024 Apr;
42(15):3455-3460.
PMID: 38658205
Background: Previous research suggested that the inactivated influenza vaccine (IIV) may protect against SARS-CoV-2 infection or a severe course of COVID-19. These findings were however based on cohort studies, that...
16.
Verheul M, Kaczorowska J, Hofstee M, Schepp R, Smits G, Wessels Beljaars D, et al.
Mucosal Immunol
. 2024 Mar;
17(4):554-564.
PMID: 38553008
Antibodies to SARS-CoV-2 on the mucosal surfaces of the respiratory tract are understood to contribute to protection against SARS-CoV-2 infection. We aimed to describe the prevalence, levels, and functionality of...
17.
van Hagen C, Huiberts A, Mutubuki E, de Melker H, Vos E, van de Wijgert J, et al.
PLoS One
. 2024 Mar;
19(3):e0300324.
PMID: 38498510
Objectives: We describe health-related quality of life during the COVID-19 pandemic in the general Dutch population and correlations with restrictive measures. Methods: Data were obtained from 18-85 year-old participants of...
18.
Huiberts A, Hoeve C, de Gier B, Cremer J, van der Veer B, de Melker H, et al.
Euro Surveill
. 2024 Mar;
29(10).
PMID: 38456217
We estimated vaccine effectiveness (VE) of SARS-CoV-2 Omicron XBB.1.5 vaccination against self-reported infection between 9 October 2023 and 9 January 2024 in 23,895 XBB.1.5 vaccine-eligible adults who had previously received...
19.
de Boer P, van Werkhoven C, van Hoek A, Knol M, Sanders E, Wallinga J, et al.
BMC Med
. 2024 Feb;
22(1):69.
PMID: 38360645
Background: New 15- and 20-valent pneumococcal vaccines (PCV15, PCV20) are available for both children and adults, while PCV21 for adults is in development. However, their cost-effectiveness for older adults, taking...
20.
Middeldorp M, Duijster J, van de Kassteele J, van der Klis F, de Melker H
Front Immunol
. 2024 Feb;
15:1327770.
PMID: 38343547
Background: This longitudinal cohort study describes the kinetics in antibody levels after two doses of the bivalent human papillomavirus (HPV) vaccine in girls (birth cohort 2001) vaccinated in the routine...